down arrow

Luyan Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: CNE1000025W1
CNY
10.88
2.32 (27.1%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Luyan Pharma Co., Ltd.
Why is Luyan Pharma Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of 6.44% and Operating profit at 4.25% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 11.96% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 6.44% and Operating profit at 4.25% over the last 5 years
3
Negative results in Mar 25
  • OPERATING CASH FLOW(Y) Lowest at CNY 602.29 MM
  • ROCE(HY) Lowest at 10.66%
  • INTEREST COVERAGE RATIO(Q) Lowest at 303.15
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Luyan Pharma Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Luyan Pharma Co., Ltd.
-100.0%
1.17
22.25%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.44%
EBIT Growth (5y)
4.25%
EBIT to Interest (avg)
3.24
Debt to EBITDA (avg)
6.98
Net Debt to Equity (avg)
1.87
Sales to Capital Employed (avg)
2.19
Tax Ratio
23.83%
Dividend Payout Ratio
39.34%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.02%
ROE (avg)
11.96%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.95
EV to EBIT
14.16
EV to EBITDA
11.57
EV to Capital Employed
0.98
EV to Sales
0.44
PEG Ratio
NA
Dividend Yield
4.38%
ROCE (Latest)
6.95%
ROE (Latest)
9.76%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.69% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 189.98 %

NET SALES(Q)

Highest at CNY 5,162.61 MM

-10What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 602.29 MM

ROCE(HY)

Lowest at 10.66%

INTEREST COVERAGE RATIO(Q)

Lowest at 303.15

INVENTORY TURNOVER RATIO(HY)

Lowest at 7.41%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.3%

OPERATING PROFIT(Q)

Lowest at CNY 145.46 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 2.82 %

Here's what is working for Luyan Pharma Co., Ltd.
Net Sales
Highest at CNY 5,162.61 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio
Lowest at 189.98 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -4.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Luyan Pharma Co., Ltd.
Interest Coverage Ratio
Lowest at 303.15
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow
Lowest at CNY 602.29 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit
Lowest at CNY 145.46 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 2.82 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio
Lowest at 7.41%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 3.3%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."